Your browser doesn't support javascript.
loading
Impact of tissue-agnostic approvals for patients with sarcoma.
Pestana, Roberto Carmagnani; Beal, Juliana Rodrigues; Parkes, Amanda; Hamerschlak, Nelson; Subbiah, Vivek.
Affiliation
  • Pestana RC; Centro de Oncologia e Hematologia Família Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: roberto.pestana@einstein.br.
  • Beal JR; Centro de Oncologia e Hematologia Família Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Parkes A; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
  • Hamerschlak N; Centro de Oncologia e Hematologia Família Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Subbiah V; Department of Investigational Cancer Therapeutics (A Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; MD Anderson Cancer Network, The Uni
Trends Cancer ; 8(2): 135-144, 2022 02.
Article de En | MEDLINE | ID: mdl-34887213
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sarcomes Type d'étude: Diagnostic_studies Limites: Humans Langue: En Journal: Trends Cancer Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sarcomes Type d'étude: Diagnostic_studies Limites: Humans Langue: En Journal: Trends Cancer Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique